Effects of dulaglutide combined with insulin degludec on time in range in type 2 diabetes mellitus

被引：0
|
作者：
黄金鑫 [1 ]
机构：
[1] Dept Endocrinol,3rd Affil Hosp,Soochow Univ
来源：
China Medical Abstracts(Internal Medicine) | 2023年 / 40卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R587.1 [糖尿病];
学科分类号：
1002 ; 100201 ;
摘要：
Objective To evaluate the effect of dulaglutide combined with insulin degludec on glucose within time in range (TIR) in patients with type 2 diabetes mellitus(T2DM).Methods A total of 116 T2DM patients who were treated in the Department of Endocrinology of The Third Affiliated Hospital of Suzhou University wereenrolled in this study from July 2020 to December 2021.
引用
收藏
页码：25 / 25
页数：1
相关论文
共 50 条
  • [1] Effects of dulaglutide combined with insulin degludec on glucose fluctuations and appetite in type 2 diabetes
    Huang, Jinxin
    Hua, Fei
    Jiang, Xiaohong
    Zhang, Xingguang
    Yang, Minxing
    Wang, Long
    Huang, Xiaolin
    Luo, Kaiming
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [2] Insulin degludec: Effects on Quality of Life in Type 2 Diabetes
    Kulzer, B.
    Wilhelm, B.
    Hermanns, N.
    DIABETES STOFFWECHSEL UND HERZ, 2015, 24 (04): : 241 - 249
  • [3] Dulaglutide (Trulicity) for Type 2 Diabetes Mellitus
    Pace, Emma
    Tingen, Jeffrey
    AMERICAN FAMILY PHYSICIAN, 2017, 96 (08) : 540 - 542
  • [4] Medium-term effects of insulin degludec on patients with type 1 diabetes mellitus
    Nakae R.
    Kusunoki Y.
    Katsuno T.
    Tokuda M.
    Akagami T.
    Murai K.
    Hamaguchi T.
    Miyagawa J.-I.
    Namba M.
    Drugs in R&D, 2014, 14 (2) : 133 - 138
  • [5] Insulin degludec and insulin degludec/insulin aspart: A guide to their use in diabetes mellitus
    Keating G.M.
    Drugs & Therapy Perspectives, 2013, 29 (10) : 297 - 302
  • [6] Effects of Switching from Insulin Glargine or Detemir to Insulin Degludec in Patients with Type 1 Diabetes Mellitus
    Kusunoki, Yoshiki
    Katsuno, Tomoyuki
    Miyakoshi, Kana
    Ikawa, Takashi
    Nakae, Rie
    Ochi, Fumihiro
    Tokuda, Masaru
    Akagami, Takafumi
    Murai, Kazuki
    Miuchi, Masayuki
    Hamaguchi, Tomoya
    Miyagawa, Jun-ichiro
    Namba, Mitsuyoshi
    DIABETES THERAPY, 2013, 4 (02) : 461 - 472
  • [7] Effects of Switching from Insulin Glargine or Detemir to Insulin Degludec in Patients with Type 1 Diabetes Mellitus
    Yoshiki Kusunoki
    Tomoyuki Katsuno
    Kana Miyakoshi
    Takashi Ikawa
    Rie Nakae
    Fumihiro Ochi
    Masaru Tokuda
    Takafumi Akagami
    Kazuki Murai
    Masayuki Miuchi
    Tomoya Hamaguchi
    Jun-ichiro Miyagawa
    Mitsuyoshi Namba
    Diabetes Therapy, 2013, 4 : 461 - 472
  • [8] Insulin Degludec and Insulin Degludec/Insulin Aspart: A Review of Their Use in the Management of Diabetes Mellitus
    Gillian M. Keating
    Drugs, 2013, 73 : 575 - 593
  • [9] Insulin Degludec and Insulin Degludec/Insulin Aspart: A Review of Their Use in the Management of Diabetes Mellitus
    Keating, Gillian M.
    DRUGS, 2013, 73 (06) : 575 - 593
  • [10] Cost-effectiveness of Insulin Degludec Versus Insulin Glargine in Adults with Type 1 and Type 2 Diabetes Mellitus
    Marc Evans
    Barrie Chubb
    Jens Gundgaard
    Diabetes Therapy, 2017, 8 : 275 - 291
12345